clinic review use long-act somatostatin analog treatment gut neuroendocrin tumor srif analog octreotid sm clinic use yr treatment acromegali metastat endocrin pancreat carcinoid tumor use analog treatment acromegali tsh-secret tumor scope clinic review patient accept analog sc rout excel side effect except develop gallston endocrin pancreat carcinoid tumor hypersecret hormon vip glucagon gastrin secretori product carcinoid tumor e.g tachykinin clinic effect excel palliat tumor patient home lead normal social live initi hope long-term octreotid therapi effect antitumor drug tumor growth experiment anim model human tumor cell line clinic practic reduct gut tumor bulk due sustain phenomenon decreas absenc clinic effect reintroduct treatment modal 